Immunovia AB Employee Directory
Biotechnology ResearchSweden51-200 Employees
Immunovia AB (publ.) is a lean, focused diagnostic company seeking to revolutionize early detection of pancreatic cancer. We aim to improve outcomes for people at high risk of pancreatic cancer by detecting the disease at Stage 1 or 2 with our highly accurate blood test, PancreaSure. Immunovia plans to launch PancreaSure in the United States in the second half of 2025. Immunovia was founded in Lund, Sweden based on protein research at Lund University. The company’s clinical lab and many of its employees are in the U.S.A., the company’s first commercial market. Immunovia stock trades on the Nasdaq Stockholm exchange under the ticker symbol IMMNOV. Visit our website for more information.